Bank Of New York Mellon Corp Geron Corp Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.14 - $3.4 $3 Million - $4.77 Million	1,403,491 New	1,403,491 $3.05 Billion
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $2.56 Million - $3.05 Million	1,261,838 New	1,261,838 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $114,112 - $200,893	68,331 Added 5.87%	1,231,967 $2.88 Million
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $2,871 - $3,981	2,413 Added 0.21%	1,163,636 $1.8 Million
Q1 2022 May 11, 2022	BUY	$0.99 - $1.6 $11,755 - $18,998	11,874 Added 1.03%	1,161,223 $1.58 Million
Q4 2021 Feb 11, 2022	BUY	$1.22 - $1.72 $37,832 - $53,337	31,010 Added 2.77%	1,149,349 $1.4 Million
Q3 2021 Nov 12, 2021	BUY	$1.2 - $1.5 $109,476 - $136,845	91,230 Added 8.88%	1,118,339 $1.53 Million
Q2 2021 Aug 11, 2021	SELL	$1.25 - $1.83 $256,827 - $375,995	-205,462 Reduced 16.67%	1,027,109 $1.45 Million
Q1 2021 May 13, 2021	SELL	$1.52 - $2.1 $963 - $1,331	-634 Reduced 0.05%	1,232,571 $1.95 Million
Q4 2020 Feb 09, 2021	BUY	$1.55 - $2.05 $152,879 - $202,195	98,632 Added 8.69%	1,233,205 $1.96 Million
Q3 2020 Nov 12, 2020	BUY	$1.59 - $2.19 $270,753 - $372,924	170,285 Added 17.66%	1,134,573 $1.97 Million
Q2 2020 Aug 12, 2020	BUY	$1.05 - $2.18 $131,592 - $273,210	125,326 Added 14.94%	964,288 $2.1 Million
Q1 2020 May 06, 2020	BUY	$0.89 - $1.49 $20,928 - $35,037	23,515 Added 2.88%	838,962 $998,000
Q4 2019 Feb 14, 2020	BUY	$1.27 - $1.54 $41,780 - $50,662	32,898 Added 4.2%	815,447 $1.11 Million
Q3 2019 Nov 07, 2019	SELL	$1.15 - $1.59 $26,199 - $36,223	-22,782 Reduced 2.83%	782,549 $1.04 Million
Q2 2019 Aug 12, 2019	BUY	$1.37 - $2.02 $109,362 - $161,250	79,827 Added 11.0%	805,331 $1.14 Million
Q1 2019 May 14, 2019	BUY	$1.01 - $1.83 $10,783 - $19,538	10,677 Added 1.49%	725,504 $1.21 Million
Q4 2018 Feb 11, 2019	SELL	$0.98 - $1.85 $61,566 - $116,222	-62,823 Reduced 8.08%	714,827 $715,000
Q3 2018 Nov 09, 2018	BUY	$1.76 - $6.38 $41,349 - $149,891	23,494 Added 3.12%	777,650 $0
Q2 2018 Aug 06, 2018	BUY	$3.29 - $4.82 $17,900 - $26,225	5,441 Added 0.73%	754,156 $2.59 Million
Q1 2018 May 15, 2018	SELL	$1.81 - $5.98 $31,490 - $104,040	-17,398 Reduced 2.27%	748,715 $3.18 Million
Q4 2017 Feb 09, 2018	BUY	$1.8 - $2.32 $1.38 Million - $1.78 Million	766,113	766,113 $1.38 Million

Others Institutions Holding GERN

# of Institutions

276

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.08B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account